Karolína Kozlanská

Karolína Kozlanská

Auto-generated profile, based on publicly available information

Karolína Kozlanská

Department of Experimental Biology, Faculty of Science, Palacký University Olomouc, Šlechtitelů 27, 78371 Olomouc, Czech Republic

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
AGAb Majeed Ganai
Ab Majeed Ganai
TPTabasum Khan Pathan
Tabasum Khan Pathan
SMSachin Balaso Mohite
Sachin Balaso Mohite
VVVeronika Vojáčková
Veronika Vojáčková
EŘEva Řezníčková
Eva Řezníčková
RKRajshekhar Karpoormath
Rajshekhar Karpoormath

Verified
Journal Article
Open access
PDF file
MTMonika Tomanová
Monika Tomanová
KKKarolína Kozlanská
Karolína Kozlanská
RJRadek Jorda
Radek Jorda
LJLukáš Jedinák
Lukáš Jedinák
THTereza Havlíková
Tereza Havlíková
VKVladimir Krystof
Vladimir Krystof
Therapy of FLT3-positive acute myeloid leukemia still remains complicated, despite the availability of newly approved kinase inhibitors. Various strategies to avoid the reduced efficacy of therapy have been explored, including the development of dual targeting compounds, which inhibit FLT3 and another kinase necessary for the survival and proliferation of AML cells. We have designed new 2,7,9-trisubstituted 8-oxopurines as FLT3 inhibitors and report here the structure-activity relationship studies. We demonstrated that substituents at positions 7 and 9 modulate activity between CDK4 and FLT3 kinase, and the isopropyl group at position 7 substantially increased the selectivity toward FLT3 kinase, which led to the discovery of compound 15a (9-cyclopentyl-7-isopropyl-2-((4-(piperazin-1-yl)phenyl)amino)-7,9-dihydro-8H-purin-8-one). Cellular analyses in MV4-11 cells revealed inhibition of autophosphorylation of FLT3 kinase in nanomolar doses, including the suppression of downstream STAT5 and ERK1/2 phosphorylation. We also describe mechanistic studies in cell lines and activity in a mouse xenograft model in vivo.

25 June 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
AGAb Majeed Ganai
Ab Majeed Ganai
TPTabasum Khan Pathan
Tabasum Khan Pathan
SMSrinivas Reddy Merugu
Srinivas Reddy Merugu
KKKarolína Kozlanská
Karolína Kozlanská
VVVeronika Vojáčková
Veronika Vojáčková
RKRajshekhar Karpoormath
Rajshekhar Karpoormath